The DOI matches its Crossref record; 225 of the 225 references it cites were found in a registry or an index.
Vaccines for preventing influenza in the elderly
Open accessAbstract
BACKGROUND: The consequences of influenza in the elderly (those age 65 years or older) are complications, hospitalisations, and death. The primary goal of influenza vaccination in the elderly is to reduce the risk of death among people who are most vulnerable. This is an update of a review published in 2010. Future updates of this review will be made only when new trials or vaccines become available. Observational data included in previous versions of the review have been retained for historical reasons but have not been updated because of their lack of influence on the review conclusions. OBJECTIVES: To assess the effects (efficacy, effectiveness, and harm) of vaccines against influenza in the elderly. SEARCH METHODS: We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (the Cochrane Library 2016, Issue 11), which includes the Cochrane Acute Respiratory Infections Group's Specialised Register; MEDLINE (1966 to 31 December 2016); Embase (1974 to 31 December 2016); Web of Science (1974 to 31 December 2016); CINAHL (1981 to 31 December 2016); LILACS (1982 to 31 December 2016); WHO International Clinical Trials Registry Platform (ICTRP; 1 July 2017); and ClinicalTrials.gov (1 July 2017). SELECTION CRITERIA: Randomised controlled trials (RCTs) and quasi-RCTs assessing efficacy against influenza (laboratory-confirmed cases) or effectiveness against influenza-like illness (ILI) or safety. We considered any influenza vaccine given independently, in any dose, preparation, or time schedule, compared with placebo or with no intervention. Previous versions of this review included 67 cohort and case-control studies. The searches for these trial designs are no longer updated. DATA COLLECTION AND ANALYSIS: Review authors independently assessed risk of bias and extracted data. We rated the certainty of evidence with GRADE for the key outcomes of influenza, ILI, complications (hospitalisation, pneumonia), and adverse events. We have presented aggregate control group risks to illustrate the effect in absolute terms. We used them as the basis for calculating the number needed to vaccinate to prevent one case of each event for influenza and ILI outcomes. MAIN RESULTS: We identified eight RCTs (over 5000 participants), of which four assessed harms. The studies were conducted in community and residential care settings in Europe and the USA between 1965 and 2000. Risk of bias reduced our certainty in the findings for influenza and ILI, but not for other outcomes.Older adults receiving the influenza vaccine may experience less influenza over a single season compared with placebo, from 6% to 2.4% (risk ratio (RR) 0.42, 95% confidence interval (CI) 0.27 to 0.66; low-certainty evidence). We rated the evidence as low certainty due to uncertainty over how influenza was diagnosed. Older adults probably experience less ILI compared with those who do not receive a vaccination over the course of a single influenza season (3.5% versus 6%; RR 0.59, 95% CI 0.47 to 0.73; moderate-certainty evidence). These results indicate that 30 people would need to be vaccinated to prevent one person experiencing influenza, and 42 would need to be vaccinated to prevent one person having an ILI.The study providing data for mortality and pneumonia was underpowered to detect differences in these outcomes. There were 3 deaths from 522 participants in the vaccination arm and 1 death from 177 participants in the placebo arm, providing very low-certainty evidence for the effect on mortality (RR 1.02, 95% CI 0.11 to 9.72). No cases of pneumonia occurred in one study that reported this outcome (very low-certainty evidence). No data on hospitalisations were reported. Confidence intervaIs around the effect of vaccines on fever and nausea were wide, and we do not have enough information about these harms in older people (fever: 1.6% with placebo compared with 2.5% after vaccination (RR 1.57, 0.92 to 2.71; moderate-certainty evidence)); nausea (2.4% with placebo compared with 4.2% after vaccination (RR 1.75, 95% CI 0.74 to 4.12; low-certainty evidence)). AUTHORS' CONCLUSIONS: Older adults receiving the influenza vaccine may have a lower risk of influenza (from 6% to 2.4%), and probably have a lower risk of ILI compared with those who do not receive a vaccination over the course of a single influenza season (from 6% to 3.5%). We are uncertain how big a difference these vaccines will make across different seasons. Very few deaths occurred, and no data on hospitalisation were reported. No cases of pneumonia occurred in one study that reported this outcome. We do not have enough information to assess harms relating to fever and nausea in this population.The evidence for a lower risk of influenza and ILI with vaccination is limited by biases in the design or conduct of the studies. Lack of detail regarding the methods used to confirm the diagnosis of influenza limits the applicability of this result. The available evidence relating to complications is of
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–225 of 225
Tsai, Y., Huang, W.-F., Wen, Y., & Chen, P. (2007) · Value in Health · doi:10.1111/j.1524-4733.2006.00158.x · Cited by 14
Isahak, I., Mahayiddin, A. A., & Ismail, R. (2007) · PubMed · Cited by 14
Glass, R. I., Brann, E. A., SLADE, J. D., Jones, W. E., Scally, M. J., Craven, R. B., & Gregg, M. B. (1978) · The Journal of Infectious Diseases · doi:10.1093/infdis/138.5.703 · Cited by 13
Efectividad de la vacuna contra influenza: metanálisis de literatura
Moreno, J., de la Hoz, F., Rico, A., Cótes, K., & Porras, A. (2009) · Biomédica · doi:10.7705/biomedica.v29i1.44 · Cited by 13
The Significance of Bacterial Superinfection in Influenza
Jarstrand, C., & Tunevall, G. (1974) · Scandinavian Journal of Infectious Diseases · doi:10.3109/inf.1974.6.issue-2.07 · Cited by 12
Hara, M., Sakamoto, T., & Tanaka, K. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.06.035 · Cited by 12
Spread of influenza: a study of risk factors in homes for the elderly in Wales.
Mukerjee, A. B. (1994) · Journal of Epidemiology & Community Health · doi:10.1136/jech.48.6.602 · Cited by 12
Outbreak of influenza A in an Ontario nursing home--January 1997.
Isaacs, S., Dickinson, C., & Brimmer, G. (1997) · PubMed · Cited by 11
Aymard, M., Mc, B., Larbaigt, G., Michaut, D., & Triau, R. (1979) · PubMed · Cited by 11
[Vaccination against influenza in the elderly. Experience with adjuvant vaccines].
Baldo, Menegon, T., Buoro, S., Scalici, C., Vesco, A., Perale, S., Boato, W., Carletti, M., Bonello, C., Dalla Costa, D., et al. (1999) · PubMed · Cited by 11
Economic Evaluations of Influenza Vaccination in the Elderly
Wood, S. C., Nguyen, V. H., & Schmidt, C. (2000) · Disease Management & Health Outcomes · doi:10.2165/00115677-200008050-00003 · Cited by 10
Adverse Reactions to Influenza Vaccine Alone or with Pneumococcal Vaccine in the Elderly
Perucchini, E., Consonni, S., Sandrini, M. C., Bergamaschini, L. C., & Vergani, C. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52327_5.x · Cited by 10
Landi, F., Onder, G., Cesari, M., Russo, A., Barillaro, C., Bernabei, R., Gambassi, G., Manigrasso, L., Pagano, F., & Gobbi, C. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2006.02.017 · Cited by 10
A comparison of adverse effects of two influenza vaccines, and the influence on subsequent uptake.
Ryan, M., & MacLeod, A. F. (1984) · PubMed Central · Cited by 9
Odelin, M., Momplot, C., Bourlet, T., Gonthier, R., Aymard, M., & Pozzetto, B. (2003) · Gerontology · doi:10.1159/000070403 · Cited by 9
[Effectiveness of anti-flu vaccine in the elderly].
Hernández, B. L., Vázquez, J., Fernández, E., Martínez, B., Romero, J., & Arribas, L. (1994) · PubMed · Cited by 9
Age‐related responses to influenza vaccination in the Newcastle region during 1983 and 1984
Howarth, D. M., Chaston, T. M., Lickiss, K. P., Weekes, J. R., O'Doherty, C., Foster, R. E., Tannock, G. A., Gillett, R. S., Hensley, M., & Bryce, D. A. (1987) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1987.tb120390.x · Cited by 9
Consonni, S., Sandrini, C., Segato, E., Perucchini, E., Bergamaschini, L. C., & Vergani, C. (2004) · Journal of preventive medicine and hygiene · Cited by 9
Nicholson, K. G., Tyrrell, D. A. J., Howells, C. H. L., Schild, G. C., & OXFORD, J. S. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90586-x · Cited by 7
Influenza vaccine efficacy in a Maryland nursing home.
Currier, M. M., Coffman, T., Boyd, P., Fremd, B., & Israel, E. (1988) · PubMed · Cited by 7
Pooling of Confounders Did Not Induce Residual Confounding in Influenza Vaccination Studies
Groenwold, R. H. H., Hak, E., & Hoes, A. W. (2009) · Annals of Epidemiology · doi:10.1016/j.annepidem.2009.02.001 · Cited by 5
[Efficacy of influenza vaccination: results in a community controlled for 2 years].
Crovari, P. C., Gasparini, R., & Crovari, P. (1980) · PubMed · Cited by 5
[Analysis of an influenza vaccination campaign in rural environment].
Iglesias, F. J. G., López, F. C. R., & Rm, B. M. (1987) · PubMed · Cited by 5
Efectividad de Un Programa de Vacunacion Antigripal en Cuatro Centros de Atencion Primaria
Badía, J. G., Muñoz, S. C., Ribé, C. C., & Rovireta, A. G. (1991) · Gaceta Sanitaria · doi:10.1016/s0213-9111(91)71071-6 · Cited by 4
Influenza immunization in elderly people.
Sloan, D. (1993) · BMJ · doi:10.1136/bmj.307.6913.1213-c · Cited by 3
Cited by
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
Osterholm, M. T., Kelley, N. S., Sommer, A., & Belongia, E. A. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70295-x · Cited by 1,789
Grohskopf, L. A., Sokolow, L. Z., Broder, K. R., Walter, E. B., Fry, A. M., & Jernigan, D. B. (2018) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6703a1 · Cited by 1,632
Negative Controls: A Tool for Detecting Confounding and Bias in Observational Studies
Lipsitch, M., Tchetgen Tchetgen, E., & Cohen, T. (2010) · Epidemiology · doi:10.1097/ede.0b013e3181d61eeb · Cited by 1,583
Vaccines for preventing pneumococcal infection in adults
Moberley, S., Holden, J., Tatham, D. P., & Andrews, R. M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000422.pub3 · Cited by 960
Guidelines for the management of adult lower respiratory tract infections - Full version
Woodhead, M., Blasi, F., Ewig, S., Garau, J., Huchon, G., Ieven, M., Ortqvist, A., Schaberg, T., Torres, A., van der Heijden, G., et al. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03672.x · Cited by 942
Metadata
- Authors
- Demicheli, V., Jefferson, T., Di Pietrantonj, C., Ferroni, E., Thorning, S., Thomas, R. E., & Rivetti, A.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2018-02-01
- Volume
- 2021
- Issue
- 10
- Pages
- CD004876-CD004876
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2136115963
- Cited by
- 695
- References
- 225
- FWCI
- 27.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.